Trevi Therapeutics (TRVI) Short Interest Ratio & Short Volume $6.47 -0.14 (-2.12%) Closing price 04:00 PM EasternExtended Trading$6.44 -0.03 (-0.46%) As of 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trevi Therapeutics Short Interest DataTrevi Therapeutics (TRVI) has a short interest of 4.68 million shares, representing 8.05% of the float (the number of shares available for trading by the public). This marks a 23.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 997,739 shares to cover all short positions.Current Short Interest4,680,000 sharesPrevious Short Interest3,790,000 sharesChange Vs. Previous Month+23.48%Dollar Volume Sold Short$31.59 millionShort Interest Ratio2.5 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares96,682,000 sharesShort Percent of Float8.05%Today's Trading Volume1,059,555 sharesAverage Trading Volume997,739 sharesToday's Volume Vs. Average106% Short Selling Trevi Therapeutics? Sign up to receive the latest short interest report for Trevi Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRVI Short Interest Over TimeTRVI Days to Cover Over TimeTRVI Percentage of Float Shorted Over Time Remove Ads Trevi Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20254,680,000 shares $31.59 million +23.5%8.1%2.5 $6.75 2/28/20253,790,000 shares $17.13 million -12.5%6.5%1.4 $4.52 2/15/20254,330,000 shares $17.62 million -5.7%7.4%2.5 $4.07 1/31/20254,590,000 shares $18.08 million +11.1%N/A2.7 $3.94 1/15/20254,130,000 shares $15.78 million +6.7%N/A2.4 $3.82 12/31/20243,870,000 shares $15.94 million -17.0%N/A2.3 $4.12 12/15/20244,660,000 shares $19.43 million +230.5%N/A2.8 $4.17 11/30/20241,410,000 shares $4.06 million -19.4%N/A2.8 $2.88 11/15/20241,750,000 shares $4.81 million +1.7%N/A3.7 $2.75 10/31/20241,720,000 shares $5.07 million +13.2%N/A4.4 $2.95 Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/20241,520,000 shares $4.83 million +0.7%N/A4.6 $3.18 9/30/20241,510,000 shares $5.04 million +8.6%N/A5.7 $3.34 9/15/20241,390,000 shares $4.68 million -10.3%N/A5.4 $3.37 8/31/20241,550,000 shares $4.90 million +3.3%N/A6.8 $3.16 8/15/20241,500,000 shares $4.13 million +16.3%N/A6.6 $2.75 7/31/20241,290,000 shares $4.10 million +1.6%N/A5.6 $3.18 7/15/20241,270,000 shares $3.62 million +32.6%N/A5.6 $2.85 6/30/2024957,600 shares $2.85 million -0.4%N/A4.4 $2.98 6/15/2024961,000 shares $2.55 million +13.1%N/A4.8 $2.65 5/31/2024849,600 shares $2.18 million -13.9%N/A4 $2.57 5/15/2024986,400 shares $2.73 million -6.1%N/A4.2 $2.77 4/30/20241,050,000 shares $3.08 million +16.9%N/A3.6 $2.93 4/15/2024898,400 shares $2.52 million -13.6%N/A3 $2.81 3/31/20241,040,000 shares $3.59 million -2.8%N/A3.5 $3.45 3/15/20241,070,000 shares $3.58 million -13.7%N/A3.8 $3.35 2/29/20241,240,000 shares $3.62 million +4.2%N/A4.2 $2.92 2/15/20241,190,000 shares $2.83 million -13.8%N/A2.7 $2.38 1/31/20241,380,000 shares $1.96 million +11.3%N/A3.6 $1.42 1/15/20241,240,000 shares $1.76 million +6.0%N/A3.2 $1.42 12/31/20231,170,000 shares $1.57 million +15.8%N/A3.1 $1.34 12/15/20231,010,000 shares $1.29 million -7.3%N/A2.8 $1.28 11/30/20231,090,000 shares $1.23 million -4.4%N/A3.4 $1.13 11/15/20231,140,000 shares $1.57 million -1.7%N/A6.4 $1.38 10/31/20231,160,000 shares $2.06 million -4.9%N/A14 $1.78 10/15/20231,220,000 shares $2.48 million -3.2%N/A18.8 $2.03 9/30/20231,260,000 shares $2.75 million -4.6%N/A17.5 $2.18 9/15/20231,320,000 shares $3.10 million +0.8%N/A14.1 $2.35 8/31/20231,310,000 shares $2.90 million -3.7%N/A6.5 $2.21 8/15/20231,360,000 shares $3.29 million +3.0%N/A4.1 $2.42 7/31/20231,320,000 shares $3.14 million +1.5%N/A3.6 $2.38Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 7/15/20231,300,000 shares $2.81 million -2.3%N/A3.3 $2.16 6/30/20231,330,000 shares $3.18 million +482.8%N/A3.5 $2.39 6/15/2023228,200 shares $588,756.00 -5.9%N/A0.6 $2.58 5/31/2023242,600 shares $524,016.00 -2.1%N/A1 $2.16 5/15/2023247,900 shares $654,456.00 -11.6%N/A1.5 $2.64 4/30/2023280,300 shares $964,232.00 +39.2%N/A3.4 $3.44 4/15/2023201,300 shares $380,457.00 +15.4%N/A3.2 $1.89 3/31/2023174,400 shares $322,640.00 +51.9%N/A3.6 $1.85 3/15/2023114,800 shares $210,084.00 +73.2%N/A1.1 $1.83 2/28/202366,300 shares $158,457.00 -15.8%N/A0.6 $2.39 2/15/202378,700 shares $201,472.00 -11.6%N/A0.7 $2.56 1/31/202389,000 shares $207,370.00 -7.0%N/A0.8 $2.33 1/15/202395,700 shares $250,734.00 +0.8%N/A0.8 $2.62 12/30/202294,900 shares $183,157.00 -40.6%N/A0.7 $1.93 12/15/2022159,800 shares $356,354.00 -34.2%N/A0.8 $2.23 11/30/2022242,800 shares $456,464.00 -16.3%N/A1.2 $1.88 11/15/2022289,900 shares $637,780.00 -1.9%N/A1.2 $2.20 10/31/2022295,600 shares $585,288.00 -27.0%N/A1.1 $1.98 10/15/2022405,100 shares $725,129.00 +264.0%N/A1.3 $1.79 9/30/2022111,300 shares $171,402.00 +12.5%N/A0.3 $1.54 9/15/202298,900 shares $306,590.00 -9.9%N/A0.1 $3.10 8/31/2022109,700 shares $348,846.00 -2.3%0.6%0.1 $3.18 8/15/2022112,300 shares $424,494.00 -19.1%0.6%0.1 $3.78 7/31/2022138,800 shares $424,728.00 -29.9%1.1%0.1 $3.06 7/15/2022198,100 shares $691,369.00 +99.3%1.5%0.1 $3.49 6/30/202299,400 shares $279,314.00 +10.3%0.8%0.1 $2.81 6/15/202290,100 shares $199,121.00 -29.7%0.8%0.1 $2.21 5/31/2022128,100 shares $310,002.00 -48.5%1.1%0.2 $2.42 5/15/2022248,800 shares $549,848.00 -37.4%2.2%0.2 $2.21 4/30/2022397,500 shares $1.07 million -27.6%11.7%0.3 $2.70 4/15/2022548,900 shares $1.80 million +66.6%3.9%0.5 $3.28 3/31/2022329,400 shares $724,680.00 -60.4%2.3%0.3 $2.20 3/15/2022832,300 shares $1.22 million +40.9%N/A1.3 $1.46 2/28/2022590,800 shares $378,112.00 +286.9%4.5%1 $0.64 2/15/2022152,700 shares $79,251.30 +95.5%1.2%0.6 $0.52 1/31/202278,100 shares $49,804.37 +4.3%0.8%0.3 $0.64 1/15/202274,900 shares $53,830.63 -34.9%0.8%0.3 $0.72 12/31/2021115,100 shares $90,031.22 +16.6%1.2%0.2 $0.78 12/15/202198,700 shares $70,767.90 +16.7%1.0%0.2 $0.72 11/30/202184,600 shares $84,143.16 -42.2%1.2%0.2 $0.99 11/15/2021146,400 shares $161,040.00 -8.3%2.1%0.3 $1.10 10/29/2021159,700 shares $187,647.50 +14.3%2.8%0.4 $1.18 10/15/2021139,700 shares $180,213.00 +25.9%2.4%0.4 $1.29 9/30/2021111,000 shares $155,400.00 +26.1%1.5%0.4 $1.40 9/15/202188,000 shares $123,200.00 +43.1%1.2%1.5 $1.40 8/31/202161,500 shares $102,090.00 -23.8%0.8%0.8 $1.66 8/13/202180,700 shares $162,610.50 +11.3%1.1%1.2 $2.02 7/30/202172,500 shares $137,750.00 -28.0%1.1%1.1 $1.90 7/15/2021100,700 shares $196,365.00 +16.7%1.6%1.4 $1.95 6/30/202186,300 shares $194,175.00 -1.9%1.3%1.3 $2.25Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 6/15/202188,000 shares $196,240.00 -6.1%1.5%1.5 $2.23 5/28/202193,700 shares $199,581.00 +11.7%1.6%2.5 $2.13 5/14/202183,900 shares $168,639.00 +36.0%1.4%1.8 $2.01 4/30/202161,700 shares $144,995.00 -30.6%1.0%1 $2.35 4/15/202188,900 shares $221,805.50 +31.7%1.5%1 $2.50 3/31/202167,500 shares $193,050.00 -46.5%1.4%0.7 $2.86 3/15/2021126,200 shares $340,740.00 +132.4%2.9%1.1 $2.70 2/26/202154,300 shares $155,298.00 -16.3%1.2%0.5 $2.86 2/12/202164,900 shares $205,733.00 +2.0%1.5%0.6 $3.17 1/29/202163,600 shares $192,708.00 +35.6%1.5%0.7 $3.03 1/15/202146,900 shares $140,700.00 +4.9%1.1%0.7 $3.00 12/31/202044,700 shares $113,538.00 -0.9%1.0%1 $2.54 12/15/202045,100 shares $132,143.00 +14.5%1.1%1.3 $2.93 11/30/202039,400 shares $121,549.00 -12.4%0.9%1.7 $3.09 11/15/202045,000 shares $151,200.00 -5.9%1.6%1.6 $3.36 10/30/202047,800 shares $152,004.00 +13.8%1.7%1.1 $3.18 10/15/202042,000 shares $153,300.00 -40.8%1.5%0.5 $3.65 9/30/202070,900 shares $285,727.00 -9.6%2.5%0.8 $4.03 9/15/202078,400 shares $301,840.00 +185.1%2.7%0.8 $3.85 8/31/202027,500 shares $110,825.00 -67.1%1.0%0.3 $4.03 8/14/202083,700 shares $490,482.00 +65.7%3.3%0.6 $5.86 7/31/202050,500 shares $250,985.00 +18.5%1.9%0.4 $4.97 7/15/202042,600 shares $218,964.00 -29.9%1.6%0.5 $5.14 6/30/202060,800 shares $417,696.00 +1.8%2.4%0.7 $6.87 6/15/202059,700 shares $271,038.00 +7,362.5%2.3%0.5 $4.54 5/29/2020800 shares $2,216.00 -97.1%0.0%0 $2.77 5/15/202027,800 shares $77,840.00 +1.5%1.1%0.4 $2.80 4/30/202027,400 shares $78,364.00 +1,342.1%1.1%0.4 $2.86 4/15/20201,900 shares $5,424.50 -77.9%0.1%0 $2.86 3/31/20208,600 shares $24,768.00 +126.3%0.3%0.1 $2.88 TRVI Short Interest - Frequently Asked Questions What is Trevi Therapeutics' current short interest? Short interest is the volume of Trevi Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 3,790,000 shares of TRVI short. 6.52% of Trevi Therapeutics' shares are currently sold short. Learn More on Trevi Therapeutics' current short interest. What is a good short interest ratio for Trevi Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TRVI shares currently have a short interest ratio of 1.0. Learn More on Trevi Therapeutics's short interest ratio. Which institutional investors are shorting Trevi Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trevi Therapeutics: J. Goldman & Co LP, Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Trevi Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.52% of Trevi Therapeutics' floating shares are currently sold short. Is Trevi Therapeutics' short interest increasing or decreasing? Trevi Therapeutics saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 3,790,000 shares, a decline of 12.5% from the previous total of 4,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Trevi Therapeutics' short interest compare to its competitors? 6.52% of Trevi Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trevi Therapeutics: Harmony Biosciences Holdings, Inc. (8.99%), Travere Therapeutics, Inc. (14.58%), Janux Therapeutics, Inc. (19.05%), Disc Medicine, Inc. (10.93%), Agios Pharmaceuticals, Inc. (7.14%), Apogee Therapeutics, Inc. (21.01%), Mesoblast Limited (2.40%), Vera Therapeutics, Inc. (15.94%), Galapagos NV (4.54%), Kiniksa Pharmaceuticals, Ltd. (9.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Trevi Therapeutics stock? Short selling TRVI is an investing strategy that aims to generate trading profit from Trevi Therapeutics as its price is falling. TRVI shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trevi Therapeutics? A short squeeze for Trevi Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRVI, which in turn drives the price of the stock up even further. How often is Trevi Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRVI, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies HRMY Short Interest Data TVTX Short Interest Data JANX Short Interest Data IRON Short Interest Data AGIO Short Interest Data APGE Short Interest Data MESO Short Interest Data VERA Short Interest Data GLPG Short Interest Data KNSA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRVI) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredAI Boom Takes a Shocking Turn…AI is Creating Fortunes… (but not where you think!) Bryce Paul and the team at Crypto101 just released a br...Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRVI Stock Free TRVI Stock Alerts